Isabelle Gaillard Selected Research

Isabelle Gaillard Research Topics

7	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 12/2009
2	Primary Ovarian Insufficiency 03/2013 - 01/2012
1	Pathologic Complete Response 01/2018
1	Neoplasms (Cancer) 10/2016
1	Hypersensitivity (Allergy) 01/2016
1	Lymphoma (Lymphomas) 03/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2011
1	Atrophy 01/2003

2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018 - 10/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 10/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 10/2016
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 10/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016
1	Dacarbazine (DIC)FDA LinkGeneric 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016
1	Vincristine (Oncovin)FDA LinkGeneric 10/2016
1	Procarbazine (Matulane)FDA Link 10/2016
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Indoleacetic Acids (Auxin)IBA 01/2016
1	CytokinesIBA 11/2013
1	Follicle Stimulating Hormone (Follitropin)FDA Link 03/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2013
1	Triptorelin Pamoate (Trelstar)FDA Link 03/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2003
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2003
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2003

4	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
2	Radiotherapy 01/2018 - 12/2015
2	Aftercare (After-Treatment) 05/2011 - 12/2009
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016
1	Therapeutics 08/2013
1	Stem Cell Transplantation 08/2013